Mainz Biomed B.V. (MYNZ) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Mainz Biomed B.V.

    NASDAQ: MYNZ · Real-Time Price · USD
    1.73
    0.09 (5.49%)
    At close: Oct 03, 2025, 3:59 PM
    1.67
    -3.76%
    After-hours: Oct 03, 2025, 07:46 PM EDT

    Mainz Biomed B.V. Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 893.99K 735.53K 714.97K 751.61K 529.88K 438.52K 577.35K 664.09K
    Cost of Revenue
    		 319.11K 365.23K 385.82K 440.31K 347.73K 464.69K 399.73K 250.01K
    Gross Profit
    		 574.88K 359.29K 318.13K 311.29K 182.15K -26.18K 177.62K 414.08K
    Operating Income
    		 -18.7M -22.04M -25.21M -25.25M -26.17M -23.37M -9.71M -418.9K
    Interest Income
    		 n/a n/a n/a 57.5K 289.32K 401.95K 339.17K 169.05K
    Pretax Income
    		 -21.65M -16.21M -18.31M -25.63M -26.39M -25.31M -11.67M -534.2K
    Net Income
    		 -21.65M -16.21M -18.45M -25.84M -26.45M -25.31M -11.67M -534.2K
    Selling & General & Admin
    		 12.77M 15.48M 16.54M 17.41M 22.81M 22.38M 9.28M 525.13K
    Research & Development
    		 5.84M 7.1M 9.1M 8.21M 3.66M 956.83K 466.69K 362.07K
    Other Expenses
    		 656.34K 1.45M 1.51M 62.74K n/a 10.75K 21.5K 26K
    Operating Expenses
    		 19.27M 24.03M 27.15M 25.7M 26.36M 24.99M 11.32M 696.3K
    Interest Expense
    		 1.08M 662.86K 809.58K 436.04K 289.32K 84.79K 169.58K 219.19K
    Selling & Marketing Expenses
    		 4.7M 3.61M 4.37M 5.22M 4.98M 3.69M 957.52K 205.53K
    Cost & Expenses
    		 19.59M 24.39M 27.54M 26.14M 26.7M 25.45M 11.66M 665.68K
    Income Tax Expense
    		 n/a n/a 146.72K -66.42K -213.14K 84.79K 84.79K 19.1K
    Shares Outstanding (Basic)
    		 968.23K 558.75K 442.04K 29.38M 14.16M 13.82M 8.81M 12.01M
    Shares Outstanding (Diluted)
    		 968.23K 558.75K 442.04K 29.38M 14.16M 14.29M 8.81M 12.01M
    EPS (Basic)
    		 -27.44 -31.46 -12.63 -1.77 -1.87 -2.3 -1.32 -0.04
    EPS (Diluted)
    		 -27.44 -31.46 -12.63 -1.79 -1.87 -2.28 -1.32 -0.04
    EBITDA
    		 -19.56M -22.08M -25.01M -24.28M -25.72M -23.34M -9.72M -365.82K
    EBIT
    		 -20.58M -22.88M -26.05M -25.18M -26.1M -23.37M -9.72M -254.63K
    Depreciation & Amortization
    		 1.02M 795.97K 1.03M 979.11K 459.43K 26.76K 6.57K 47.87K

    Add to Watchlist